<aside> 🔍

The biostimulants market is on a fast track to more than double by 2032, driven by M&A activity by major agro-players. While Europe still leads the way, momentum is clearly shifting as growth picks up across new geographies. The market is structuring around two main types:

• The non-microbial products, currently leading the market: they are scalable, easy to formulate, and widely used, especially in regions like Europe and India
• The microbial products, the fastest-growing segment while still smaller in volume: they offer technical, tailored and innovative solutions

The entry barriers for microbial products may be higher, but so is the potential for meaningful differentiation.

</aside>

📈 The market is projected to grow by x2.4 by 2032, driven by acquisition

Untitled

<aside> <img src="/icons/promoted_green.svg" alt="/icons/promoted_green.svg" width="40px" />

Valued at $4.03 billion in 2024, the market is expected to more than double by 2032, reaching $9.75 billion, propelled by a strong CAGR of 11.8%

</aside>

<aside> <img src="/icons/globe_green.svg" alt="/icons/globe_green.svg" width="40px" />

European players remain influential, especially in setting regulatory and sustainability standards, but new demand is shifting globally

While Europe remains the historical stronghold, accounting for nearly 40% of the global market, the most dynamic growth is now occurring in emerging regions

</aside>

<aside> <img src="/icons/pull-request_green.svg" alt="/icons/pull-request_green.svg" width="40px" />

This acceleration is reflected in startup M&A activity, as large agri-players move to secure innovation pipelines:

BCF Life Sciences acquired Sparkfood (2024) ; ELEPHANT VERT acquired Lipofabrik (2022) and BIO3G (2024) ; ICL Growing Solutions integrated core assets of Lavie Bio (2025) ; Lesaffre aquired Agrauxine then ABM (2021) ; Nichino aquired Interagro (2023) ; Rovensa Group acquired Agro-K (2023) ; Sumitomo Chemical acquired FBSciences (2023) ; VEOS Group acquired Mycorena (2024), etc.

</aside>

2️⃣ Two main pillars structure the market

Global biostimulants market share (%)

The biostimulant market is structured around two key pillars: non-microbial and microbial:

<aside>

• Non-microbial biostimulants

Their ease of adoption makes them perfect for rapid scaling, but as competition heats up, it becomes harder to stand out. ****Innovation and uniqueness are now essential.

</aside>

<aside>

• Microbial biostimulants

Microbial biostimulants represent a more technical, innovation-driven segment, making them harder to copy. They offer great long-term differentiation, as agriculture shifts towards regenerative practices.

</aside>